Remove Congenital Remove Heart Disease Remove Ultrasound
article thumbnail

Diagnostic accuracy of artificial intelligence models in detecting congenital heart disease in the second-trimester fetus through prenatal cardiac screening: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

BackgroundCongenital heart disease (CHD) is a major contributor to morbidity and infant mortality and imposes the highest burden on global healthcare costs. Most studies utilized deep learning models using either ultrasound or echocardiographic images.

article thumbnail

New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

DAIC

Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer. In structural heart disease, the quality of a 3D TEE image can help save lives.

article thumbnail

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.

article thumbnail

Overcoming the Odds with Expert Fetal Cardiology Care: Zeke and Zane’s Story

Conquering CHD

Zeke and Zane were both diagnosed with hypoplastic left heart syndrome (HLHS) before birth. As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. The Heart Institute collaborates with the CFCC through the Fetal Cardiology Program.

article thumbnail

CHD-CXR: a de-identified publicly available dataset of chest x-ray for congenital heart disease

Frontiers in Cardiovascular Medicine

Congenital heart disease is a prevalent birth defect, accounting for approximately one-third of major birth defects. In response, we have released a dataset containing 828 DICOM chest x-ray files from children with diagnosed congenital heart disease, alongside corresponding cardiac ultrasound reports.

article thumbnail

Creative concepts article: Potential applications of ultrasound-based leadless endocardial pacing in adult congenital heart disease

HeartRhythm

Cardiac device therapy is frequently required for individuals with adult congenital heart disease (ACHD), whether it be for bradyarrhythmia, ventricular tachyarrhythmia, or cardiac resynchronization therapy (CRT).